Clinical trials: Silodosin
Benign Prostatic Hyperplasia
Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
The purpose of this study is to confirm in a larger population in Europe the effectiveness and safety observed with silodosin in previous clinical trials.
- Trial name
- SiRE (NCT01757769)
- Testing
- Silodosin
- Where
- Italy
- Volunteers
- 1,036 people
- Sponsor
- RECORDATI GROUP
Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Objective: To evaluate the efficacy and safety of Silodosin Capsules in the treatment of Benign Prostatic Hyperplasia (BPH) with Lower Urinary Tract Symptoms (LUTS) compared with Tamsulosin Hydrochloride Sustained Release…
- Trial name
- NCT05551221
- Testing
- Silodosin Capsules, Tamsulosin
- Where
- 8 sites in China
- Volunteers
- 110 people
- Sponsor
- Xintian Pharmaceutical
Ureteral Calculi, Kidney Stones
Study of Silodosin to Facilitate Passage of Urinary Stones
The purpose of this study is to assess if patients treated with silodosin will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.
- Conditions
- Ureteral Calculi, Kidney Stones, Urolithiasis
- Trial name
- NCT01144949
- Testing
- silodosin
- Where
- 27 sites in United States
- Volunteers
- 239 people
- Sponsor
- Watson Pharmaceuticals
Prostatic Hyperplasia
The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention
Acute urine retention, AUR, is often considered the most serious consequence of aging men with progressive benign prostatic hyperplasia (BPH). AUR is defined as the sudden and painful inability to void freely.
- Trial name
- NCT06319469
- Testing
- silodosin 8 mg capsule and the pyridostigmine bromide 60 mg tablet, silodosin 8 mg capsule
- Where
- Egypt
- Volunteers
- 140 people
- Sponsor
- Beni-Suef University
Kidney Stone, Expulsive Medical Therapy
Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.
In the diagnosis of renal colic gallstone , in addition to clinical and biological factors, it is a key : medical imaging. Currently , the French recommendations require at least a couple of Abdomen radiography Without…
- Trial name
- SiloMET (NCT02090439)
- Testing
- Silodosin
- Where
- 2 sites in France
- Volunteers
- 8 people
- Sponsor
- Centre Hospitalier Departemental Vendee
Nocturia, Prostatic Hyperplasia
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Silodosin is compared to placebo to determine if it is safe and effective for the treatment of nighttime urination (nocturia) in men with BPH
- Trial name
- NCT00793819
- Testing
- silodosin
- Where
- 27 sites in United States
- Volunteers
- 215 people
- Sponsor
- Watson Pharmaceuticals
Kidney Stones
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
Tamsulosin is an alpha blocker usually prescribed for urinary complaints that has been shown to have some benefit in allowing kidney stones to pass through the ureter.
- Trial name
- NCT01560091
- Testing
- silodosin, Extra-corporeal shock wave lithotripsy, Tamsulosin
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Albert Einstein Healthcare Network
Acute Urinary Retention, Benign Prostatic Hyperplasia
Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention
This randomized controlled trial will compare three medication strategies before trial without catheter in men with acute urinary retention due to benign prostatic hyperplasia who were already taking tamsulosin 0.4 mg once daily…
- Trial name
- NCT07650968
- Testing
- Tamsulosin 0.4 mg, Tamsulosin 0.8 mg, Silodosin 8 mg
- Where
- Egypt
- Volunteers
- 378 people
- Sponsor
- Beni-Suef University
Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom
Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin
This observational study aims to evaluate the relationship between silodosin-induced anejaculation and clinical outcomes in male patients with benign prostatic obstruction (BPO).
- Conditions
- Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom, Ejaculatory Dysfunction, Anejaculation
- Trial name
- NCT06989515
- Volunteers
- 100 people
- Sponsor
- Marmara University
Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia
This is a randomized, double-blind, controlled, non-inferiority multicenter Phase III clinical study to evaluate the efficacy and safety of H077 sustained-release tablets versus silodosin capsules in treating benign prostatic…
- Trial name
- NCT07146386
- Testing
- H077 sustained-release tablet, Silodosin capsules Control Group
- Where
- 66 sites in China
- Volunteers
- 728 people
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
Urolithiasis
Silodosin in Retrograde Intrarenal Surgery
Selective alpha-blockers have been used for the treatment of ureteric stones as medical expulsive therapy (MET). Recently they have been successfully used in passive ureteric dilatation before semirigid ureteroscopy.
- Trial name
- NCT05921370
- Testing
- Silodosin 8 mg
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Ain Shams University
BPH (Benign Prostatic Hyperplasia)
The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
The goal of this clinical trial is to learn if Qianweitai (QWT, silodosin capsule) works to treat BPH/LUTS in male adults. It will also learn the safety about QWT. The main questions it aims to answer are: 1.
- Trial name
- NCT07134907
- Testing
- Silodosin, Tamsolusin
- Where
- 6 sites in China
- Volunteers
- 110 people
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
Multiple Sclerosis, Lower Urinary Track Symptoms
Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
The goal of this clinical trial is to learn if silodosin works to treat lower urinary tract symptoms (LUTS) in female patients with multiple sclerosis (MS). It will also learn about the effect of the drug on voiding parameters.
- Trial name
- NCT07614321
- Testing
- Silodosin 8 mg
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Atlantic Health System
Urinary Calculus
A Dose-finding Study of Silodosin in Patients With Urinary Calculi
The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.
- Trial name
- NCT01539265
- Testing
- silodosin
- Where
- Japan
- Volunteers
- 300 people
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
Ureteral Stone
Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones
A lower ureteral calculus, which measures 5 millimeters and less, may be easily expelled by symptomatic therapy. Actually, it has about a 50% chance of successful expulsion.
- Trial name
- STONE (NCT01533389)
- Testing
- Silodosin
- Where
- 5 sites in South Korea
- Volunteers
- 114 people
- Sponsor
- JW Pharmaceutical
Stone Ureter, Stone, Kidney
Silodosin in Facilitating Flexible Uretroscopy
This study aims to provide robust evidence on whether a specific, potent pre-operative medication (silodosin) can make the critical step of ureteral access (UAS placement after dilation) easier and safer during f-URS for kidney…
- Trial name
- NCT07068087
- Testing
- Preoperative sioldosin to facilitate ureteric access sheath insertion in RIRS
- Where
- Egypt
- Volunteers
- 42 people
- Sponsor
- Ain Shams University
Lower Ureteric Stones, Medical Expulsive Therapy
Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones
This study will compare the efficacy of silodosin, tadalafil versus silodosin plus tadalafil as Medical Expulsive Therapy (MET) for lower ureteric stones.
- Conditions
- Lower Ureteric Stones, Medical Expulsive Therapy, Tadalafil, Silodosin
- Trial name
- NCT05789732
- Testing
- Silodosin, Tadalafil, Silodosin and Tadalafil
- Where
- Egypt
- Volunteers
- 168 people
- Sponsor
- Benha University
Lower Ureteral Stones
Comparative Study for Medical Therapy for Lower Ureteral Stones
The goal of this clinical trial is to compare the efficacy and adverse effects of different drugs as a medical expulsive therapy for lower ureteral stones.
- Trial name
- NCT06707181
- Testing
- • The study will include 180 randomly selected patients who met inclusion criteria were randomized into four groups: silodosin 8 mg (Group A), tamsulosin 0.4 mg (Group B), silodosin 8 mg plus tadalaf
- Where
- Egypt
- Volunteers
- 180 people
- Sponsor
- Beni-Suef University
Urolithiasis, Ureteral Injury
Effect of Preoperative Alpha-blockers on Successful Insertion Ureteral Access Sheath and Reduce Ureteral Injury in Non-prestented Patients During RIRS. Assessment of Factors for Successful Ureteral Access Sheath Insertion.
The aim of the study is to evaluate the effect of preoperative taking alpha-blockers (tamsulosin or silodosin) on the success rate of ureteral access sheath (UAS) insertion and the degree of ureteral injury during RIRS in…
- Conditions
- Urolithiasis, Ureteral Injury, Ureteral Access Sheath, Retrograde Intrarenal Surgery
- Trial name
- NCT07202923
- Where
- Russia
- Volunteers
- 140 people
- Sponsor
- St. Luke's Clinical Hospital, Russia
Stone, Urinary
Silodosin vs Tamsulosin as MET
The spontaneous passage rate for ureteral stone less than 1cm causing acute ureteral obstruction is about 50%. Previous Cochrane review has concluded that alpha blocker is likely to increase stone passage rate, reduce time to…
- Trial name
- NCT05570084
- Testing
- Silodosin, Tamsulosin
- Where
- Hong Kong
- Volunteers
- 80 people
- Sponsor
- Princess Margaret Hospital, Hong Kong